Moderna completes enrollment in its large COVID-19 vaccine study

London, October 22

Moderna Inc said on Thursday it had completed enrolling 30,000 participants in a late-stage study testing its experimental coronavirus vaccine.

Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273, the company said.

Moderna said its study includes more than 11,000 participants from minority communities in the US, representing 37 per cent of the study population. Reuters